Association between use of proton pump inhibitors and survival of patients with colorectal cancer
Dr. Nele Brusselaers
Proton pump inhibitors are associated with microbiome changes in the gut, which in turn may affect the progression of colorectal cancer. A population-based cohort study in Sweden found that PPI use after a CRC diagnosis was associated with increased all-cause and CRC-specific mortality.
